Arcus Biosciences
RCUS
RCUS
131 hedge funds and large institutions have $1.68B invested in Arcus Biosciences in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 51 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more ownership
Funds ownership: 63.62% → 67.62% (+4%)
1% more funds holding
Funds holding: 130 → 131 (+1)
29% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 51
Holders
131
Holding in Top 10
9
Calls
$4.84M
Puts
$1.37M
Top Buyers
| 1 | +$62.3M | |
| 2 | +$20.3M | |
| 3 | +$16.5M | |
| 4 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
+$15.9M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$15.1M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$12.5M | |
| 3 | -$12.3M | |
| 4 |
Renaissance Technologies
New York
|
-$7.57M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.65M |